OTC Markets Group Inc. (OTCQX:OTCM) announced that ONWARD Medical NV, a medtech firm developing spinal cord stimulation therapies, has begun trading on the OTCQX Market.
CEO Dave Marver said the listing expands access for US investors and improves visibility and liquidity.
"This milestone not only marks a significant achievement for the company but also highlights the interplay between the European capital markets and U.S. investors seeking new investment opportunities,” OTC’s Jason Paltrowitz added.
ONWARD also launched a Level 1 ADR program to ease trading.